1.Current status of liver diseases in Korea: Toxic and alcoholic liver diseases.
The Korean Journal of Hepatology 2009;15(Suppl 6):S29-S33
The study of the epidemiology of toxic liver injury has been limited in Korea. The number of hospitalizations for toxic liver injury has been estimated to be 2,400 persons per year. About 30~40% of fulminant hepatitis was attributed to toxic hepatitis. The frequent causative agents of toxic hepatitis in Korea are herbal medicines (34~40%), folk remedies (23~34%), and prescribed medicines (24~55%). However, the most common agents causing severe liver injury including fulminant hepatitis are herbal medicine and folk remedies. Antituberculosis drugs and acetaminophen are two common causes of fulminant hepatitis among prescribed drugs. Alcohol is one of the leading causes of chronic liver disease in Korea. No nationwide study on the epidemiology of alcoholic liver disease (ALD) has been carried out, but 7~31% of cirrhosis has been reported to be alcoholic in a few single-center studies. Alcohol could be a risk factor for the development of hepatocellular carcinoma (HCC) in chronic viral hepatitis. Several studies have shown that alcohol increased the risk of HCC in liver cirrhosis with HBsAg or anti-HCV. Furthermore, alcoholic cirrhosis with occult hepatitis B virus infection increased the risk of HCC.
Drug-Induced Liver Injury/diagnosis/*epidemiology/etiology
;
Humans
;
Korea/epidemiology
;
Liver Cirrhosis, Alcoholic/complications/epidemiology
;
Liver Diseases, Alcoholic/complications/*epidemiology
;
Liver Neoplasms/etiology
;
Risk Factors
2.Occult Hepatitis B Virus Infection and Hepatocellular Carcinoma.
The Korean Journal of Gastroenterology 2013;62(3):160-164
Many studies have suggested that occult HBV infection has a substantial clinical relevance to hepatocellular carcinoma (HCC). Occult HBV infection is an important risk factor for the development of cirrhosis and HCC in patients without HBsAg. As a matter of fact, occult HBV infection is one of the most common causes of crytogenic HCC in endemic areas of HBV. However, there still are controversial issues about the association between occult HBV infection and HCC according to the underlying liver disease. In alcoholic cirrhosis, occult HBV infection may exert synergistic effect on the development of HCC. However, there is insufficient evidence to relate occult HBV infection to hepatocarcinogenesis in non-alcoholic fatty liver disease. In cryptogenic HCC, occult HBV infection may play a direct role in the development of HCC. In order to elucidate the assocciation between occult HBV infection and HCC, underlying liver disease must be specified and larger number of cases must be included in future studies.
Carcinoma, Hepatocellular/*complications/*diagnosis/epidemiology
;
DNA, Viral/analysis
;
Hepatitis/complications
;
Hepatitis B/*complications/*diagnosis/epidemiology
;
Hepatitis B virus/genetics
;
Humans
;
Liver Cirrhosis, Alcoholic/complications
;
Liver Neoplasms/*complications/*diagnosis/epidemiology
;
Risk Factors
3.Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection.
The Korean Journal of Hepatology 2009;15(1):7-14
Hepatocellular carcinoma (HCC) is associated with hepatitis B virus (HBV) as an etiologic agent in 80% of cases, and is the major cause of death among HBV carriers. Family history of HCC is a known risk factor for the development of HCC among chronically HBV infected patients; therefore, genetic factors are likely to modify the risk of HCC. However, the genetic factors that determine progression to HCC remain mostly to be recovered. It is estimated that there are millions of single nucleotide polymorphisms (SNPs) within human genome and they are likely to explain much of the genetic diversity of individuals. In this review, the natural history of HBV infection and host genetic factors related to HCC, study design and target gene selection for the detection of SNPs related to the occurrence of HCC were discussed. Also, several SNPs or haplotypes, which were reportedly associated with increased or reduced risk of HCC occurrence in patients with chronic HBV infection, were reviewed. Especially, recent studies in Korea, one of the HBV endemic areas, were discussed. Screening of these polymorphisms might be useful in clinical practice to stratify the lower or higher risk group for HCC and might modify the design of HCC surveillance programs in patients with chronic HBV infection, if further genetic susceptibilities are identified. The ongoing studies of the distributions and functions of the implicated allele polymorphisms will not only provide insight into the pathogenesis of HCC, but may also provide a novel rationale for new methods of diagnosis and therapeutic strategies.
Biological Markers
;
Carcinoma, Hepatocellular/diagnosis/*epidemiology/*genetics
;
Genetic Predisposition to Disease
;
Hepatitis B, Chronic/*complications/diagnosis/epidemiology
;
Humans
;
Liver Neoplasms/diagnosis/*epidemiology/*genetics
;
*Polymorphism, Single Nucleotide
4.Type and cause of liver disease in Korea: single-center experience, 2005-2010.
Sang Soo LEE ; Young Sang BYOUN ; Sook Hyang JEONG ; Yeo Myung KIM ; Ho GIL ; Bo Young MIN ; Mun Hyuk SEONG ; Eun Sun JANG ; Jin Wook KIM
Clinical and Molecular Hepatology 2012;18(3):309-315
BACKGROUND/AIMS: The aim of this study was to describe the types and causes of liver disease in patients from a single community hospital in Korea between April 2005 and May 2010. METHODS: A cohort of patients who visited the liver clinic of the hospital during the aforementioned time period were consecutively enrolled (n=6,307). Consistent diagnostic criteria for each liver disease were set by a single, experienced hepatologist, and the diagnosis of all of the enrolled patients was confirmed by retrospective review of their medical records. RESULTS: Among the 6,307 patients, 528 (8.4%) were classified as acute hepatitis, 3,957 (62.7%) as chronic hepatitis, 767 (12.2%) as liver cirrhosis, 509 (8.1%) as primary liver cancer, and 546 (8.7%) as a benign liver mass or other diseases. The etiologies in the acute hepatitis group in decreasing order of prevalence were hepatitis A (44.3%), toxic hepatitis (32.4%), other hepatitis viruses (13.8%), and cryptogenic hepatitis (9.1%). In the chronic hepatitis group, 51.2% of cases were attributed to viral hepatitis, 33.3% to nonalcoholic fatty liver disease, and 13.0% to alcoholic liver disease (ALD). Of the cirrhoses, 73.4% were attributable to viral causes and 18.1% to alcohol. Of the hepatocellular carcinoma cases, 86.6% were attributed to viral hepatitis and 11.6% to ALD. Among the benign tumors, hemangioma comprised 52.2% and cystic liver disease comprised 33.7%. CONCLUSIONS: Knowledge of the current status of the type and cause of liver disease in Korea may be valuable as a basis for evaluating changing trends in liver disease in that country.
Acute Disease
;
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Alcohol Drinking/adverse effects
;
Carcinoma, Hepatocellular/epidemiology/etiology/pathology
;
Chronic Disease
;
Cohort Studies
;
Fatty Liver/epidemiology
;
Female
;
Hepatitis/epidemiology
;
Hepatitis, Viral, Human/complications/epidemiology
;
Humans
;
Liver Cirrhosis/epidemiology/etiology
;
Liver Diseases/*diagnosis/epidemiology
;
Liver Diseases, Alcoholic/complications/epidemiology
;
Liver Neoplasms/epidemiology/etiology/pathology
;
Male
;
Middle Aged
;
Prevalence
;
Republic of Korea/epidemiology
;
Retrospective Studies
;
Young Adult
5.The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis.
Min Ju KIM ; Oh Sang KWON ; Nak So CHUNG ; Seo Young LEE ; Hyuk Sang JUNG ; Dong Kyun PARK ; Yang Suh KU ; Yu Kyung KIM ; Yun Soo KIM ; Ju Hyun KIM
The Korean Journal of Hepatology 2008;14(1):67-76
BACKGROUND/AIMS: Alcohol and the hepatitis B virus (HBV) exert synergistic effects in hepatocelluar carcinogenesis. We aimed to elucidate the clinical significance of the antibody to hepatitis B core antigen (anti-HBc) and occult HBV infection on the development of hepatocellular carcinoma (HCC) in patients with alcoholic liver cirrhosis (LC). METHODS: Patients with alcoholic LC alone (n=193) or combined with HCC (n=36), who did not have HBsAg or antibody to hepatitis C virus were enrolled. Clinical data and laboratory data including anti-HBc were investigated at enrollment. The polymerase chain reaction was applied to HBV DNA using sera of patients with HCC or LC after age and sex matching. RESULTS: Patients with HCC were older (60+/-11 years vs. 53+/-10 years, mean+/-SD, P<0.001), more likely to be male (100% vs. 89%, P=0.03), and had a higher positive rate of anti-HBc (91.2% vs. 77.3%, P=0.067), and a higher alcohol intake (739+/-448 kg vs. 603+/-409 kg, P=0.076) than those with LC. Age was the only significant risk factor for HCC revealed by multiple logistic regression analysis (odds ratio, 1.056; P=0.003). The positive rate of anti-HBc and alcohol intake did not differ in age- and sex-matched subjects between the LC (n=32) and HCC (n=31) groups. However, the detection rate of serum HBV DNA was higher in the HCC group (48.4%) than in the LC group (0%, P<0.001). CONCLUSIONS: Anti-HBc positivity is not a risk factor for HCC. However, occult HBV infection may be a risk factor for HCC in patients with alcoholic LC.
Adult
;
Aged
;
Antibodies, Viral/blood
;
Carcinoma, Hepatocellular/diagnosis/epidemiology/*etiology
;
DNA, Viral/analysis
;
Female
;
Hepatitis B/*complications/diagnosis
;
Hepatitis B Core Antigens/*immunology
;
Hepatitis B Surface Antigens/immunology
;
Hepatitis B virus/genetics/immunology/isolation & purification
;
Hepatitis C/complications/diagnosis
;
Humans
;
Liver Cirrhosis, Alcoholic/*complications/diagnosis/epidemiology
;
Liver Neoplasms/diagnosis/epidemiology/*etiology
;
Male
;
Middle Aged
;
Risk Factors
6.Hepatitis B and C Virus Infection and Liver Dysfunction in Patients Receiving Chemotherapy.
Chang Il KWON ; Ji Hyun LEE ; Ki Hyun CHOI ; Kwang Hyun KO ; Sung Pyo HONG ; Seong Gyu HWANG ; Pil Won PARK ; Doyeun OH ; Kyu Sung RIM ; Sehyun KIM
The Korean Journal of Gastroenterology 2006;48(6):408-414
BACKGROUND/AIMS: Liver dysfunction and reactivation of hepatitis virus are well-described complications in cancer patients who receive cytotoxic chemotherapy and may result in varying degrees of liver damage. However, there has been just few reports on such complications and on the preemptive use of lamivudine in Korea. The aims of this study were to determine the prevalence of hepatitis B and C virus infection and the incidence of liver dysfunction in patients with malignancies who receive chemotherapy, to determine the reactivation rate of hepatitis B virus (HBV) in those patients, to evaluate the effect of preemptive use of lamivudine in patients with HBV infection. METHODS: Among 1,477 patients who received chemotherapy due to various malignancies from January 2000 to June 2005, 668 patients with incomplete viral studies or hepatitis related malignancy were excluded. A retrospective study was conducted by reviewing the medical records of remaining 809 patients. RESULTS: The overall prevalence rate of hepatitis B or C virus in patients receiving chemotherapy was 6.55% (53/809). The incidences of liver dysfunction was not significantly different between hepatitis virus positive group and negative group. Reactivation rate of hepatiris B or C virus after chemotherapy was 15% (6/40). In all patients who received lamivudine therapy, aspartate aminotransferase and alanine aminotransferase level were normalized and HBV DNA negativity achieved. CONCLUSIONS: The existence of hepatitis virus in patients receiving chemotherapy did not significantly influence the development of severe liver dysfunction, owing probably to the lamivudine therapy. Further prospective studies are required to ascertain the reactivation of hepatitis virus in patients receiving chemotherapy and the need for prophylactic lamivudine therapy in HBV positive patients.
Adult
;
Antineoplastic Agents/*adverse effects
;
Antiviral Agents/*therapeutic use
;
Female
;
Hepatitis B/diagnosis/epidemiology/*prevention & control
;
Hepatitis C/diagnosis/epidemiology/*prevention & control
;
Humans
;
Lamivudine/*therapeutic use
;
Liver Diseases/chemically induced/*diagnosis/epidemiology
;
Male
;
Middle Aged
;
Neoplasms/complications/drug therapy
;
Prevalence
7.Comparison of usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B endemic area.
So Young BAE ; Moon Seok CHOI ; Geum Youn GWAK ; Yong Han PAIK ; Joon Hyoek LEE ; Kwang Cheol KOH ; Seung Woon PAIK ; Byung Chul YOO
Clinical and Molecular Hepatology 2012;18(2):185-194
BACKGROUND/AIMS: We compared the accuracy and usefulness of clinical diagnostic criteria for hepatocellular carcinoma in a hepatitis B virus (HBV)-endemic area. METHODS: We reviewed the medical records of 355 patients who had undergone liver resection or biopsy at our institution between January 2008 and December 2009. These patients were reevaluated using four noninvasive diagnostic criteria for hepatocellular carcinoma proposed by the European Association for the Study of the Liver (EASL), the American Association for the Study of Liver Diseases (AASLD), the Korean Liver Cancer Study Group and the National Cancer Center (KLCSG/NCC), and National Comprehensive Cancer Network (NCCN) guidelines. RESULTS: The overall sensitivity was highest using the KLCSG/NCC criteria (79.8%), followed by the AASLD (51.5%), EASL (38.4%), and NCCN (10.1%; P<0.001) criteria, whereas the specificity (84.5-98.3%) and positive predictive value (96.2-98.3%) were similar for all of the criteria. The KLCSG/NCC criteria had an acceptable false-positive rate and the highest sensitivity among all of the patients, including those positive for HBsAg, those without liver cancer, and those with a tumor of at least 2 cm. CONCLUSIONS: The KLCSG/NCC and AASLD criteria exhibited the highest sensitivity, and all four guidelines had a high specificity among all of the patients. Based on the sensitivity and false-positive rate, the KLCSG/NCC criteria was the most useful in the majority of patients. Inclusion of HBV infection in the clinical diagnostic criteria for hepatocellular carcinoma would be reasonable and may lead to an improvement in the sensitivity, with acceptable false-positive rates, in HBV-endemic areas.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Hepatocellular/*diagnosis/etiology/pathology
;
Female
;
Hepatitis B/complications/*diagnosis/epidemiology
;
Hepatitis B Surface Antigens/blood
;
Hepatitis C/diagnosis/epidemiology
;
Humans
;
Liver/pathology
;
Liver Neoplasms/*diagnosis/etiology/pathology
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Practice Guidelines as Topic
;
Predictive Value of Tests
;
Retrospective Studies
;
Risk Factors
;
Tomography, X-Ray Computed
;
Young Adult
;
alpha-Fetoproteins/analysis